Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Berger

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Heart (British Cardiac Society)|September 25, 2007
Effects of glycoprotein IIb/IIIa blockersArun Kalyanasundaram, Peter Berger, Adnan Kastrati
Experimental Gerontology|June 25, 2008
Increase of Dkk-3 blood plasma levels in the elderlyChristoph Zenzmaier, Lilian Sklepos, Peter Berger
Wiener Klinische Wochenschrift|August 30, 2008
[Pathophysiology and therapy of benign prostatic hyperplasia]Natalie Sampson, Stephan Madersbacher, Peter Berger
European Urology|February 26, 2014
Re: Delila Gasi Tandefelt, Joost L. Boormans, Hetty A. van der Korput, Guido W. Jenster, Jan Trapman. A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers. Eur Urol 2013;64:941-50Natalie Sampson, Peter Berger, Helmut Klocker
International Journal of Offender Therapy and Comparative Criminology|September 16, 2003
Sexual sadismWolfgang Berner, Peter Berger, Andreas Hill
Gerontology|October 27, 2016
The Potential of sGC Modulators for the Treatment of Age-Related Fibrosis: A Mini-ReviewPeter Sandner, Peter Berger, Christoph Zenzmaier
Biomed Research International|April 5, 2014
Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic diseaseNatalie Sampson, Peter Berger, Christoph Zenzmaier
Pharmacotherapy|September 12, 2002
Toxic epidermal necrolysis after celecoxib therapyPeter Berger, Daniel Dwyer, Carmela E Corallo
The Prostate|June 15, 2013
Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancerChristoph Zenzmaier, Natalie Sampson, Eugen Plas, et al.
International Journal of Oncology|September 1, 2011
Dickkopf-3 maintains the PANC-1 human pancreatic tumor cells in a dedifferentiated stateChristoph Zenzmaier, Martin Hermann, Paul Hengster, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Heart (British Cardiac Society)|September 25, 2007
Effects of glycoprotein IIb/IIIa blockersArun Kalyanasundaram, Peter Berger, Adnan Kastrati
Experimental Gerontology|June 25, 2008
Increase of Dkk-3 blood plasma levels in the elderlyChristoph Zenzmaier, Lilian Sklepos, Peter Berger
Wiener Klinische Wochenschrift|August 30, 2008
[Pathophysiology and therapy of benign prostatic hyperplasia]Natalie Sampson, Stephan Madersbacher, Peter Berger
European Urology|February 26, 2014
Re: Delila Gasi Tandefelt, Joost L. Boormans, Hetty A. van der Korput, Guido W. Jenster, Jan Trapman. A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers. Eur Urol 2013;64:941-50Natalie Sampson, Peter Berger, Helmut Klocker
International Journal of Offender Therapy and Comparative Criminology|September 16, 2003
Sexual sadismWolfgang Berner, Peter Berger, Andreas Hill
Gerontology|October 27, 2016
The Potential of sGC Modulators for the Treatment of Age-Related Fibrosis: A Mini-ReviewPeter Sandner, Peter Berger, Christoph Zenzmaier
Biomed Research International|April 5, 2014
Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic diseaseNatalie Sampson, Peter Berger, Christoph Zenzmaier
Pharmacotherapy|September 12, 2002
Toxic epidermal necrolysis after celecoxib therapyPeter Berger, Daniel Dwyer, Carmela E Corallo
The Prostate|June 15, 2013
Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancerChristoph Zenzmaier, Natalie Sampson, Eugen Plas, et al.
International Journal of Oncology|September 1, 2011
Dickkopf-3 maintains the PANC-1 human pancreatic tumor cells in a dedifferentiated stateChristoph Zenzmaier, Martin Hermann, Paul Hengster, et al.
Pageof 11